AACN has published a new edition of “AACN Scope and Standards for Acute Care Nurse Practitioner Practice” to reflect the specialty’s evolving role and an ever-changing critical care landscape.
First issued in 2006 and previously updated in 2012, the new edition describes and measures the expected level of practice and professional performance for acute care nurse practitioners (ACNPs). The 2017 edition, which came from collaboration from a work group of ACNP subject matter experts convened by AACN collaborated to update the content to reflect current practice incorporates advances in scientific knowledge, clinical practice, technology and other changes in the dynamic healthcare environment. It addresses the full scope of practice for ACNPs, including those whose education and training prepare them to care for children with acute and critical illnesses. It also aligns with the “Consensus Model for APRN Regulation” — also called the LACE Model — developed to create national congruence for licensure, accreditation, certification, and education of advanced practice nurses.
“The role of acute care nurse practitioners continues to expand as more hospitals and healthcare organizations discover the value of having ACNPs on staff,” said Linda Bell, AACN clinical practice specialist and editor of the publication. “Patients who used to be hospitalized are now cared for throughout the healthcare system. As a result, the services or care provided by ACNPs and other advanced practice providers are not defined or limited by setting but rather by patient care needs.”
These standards are a valuable resource for acute care pediatric nurse practitioners (CPNP-AC), adult ACNPs (ACNPC-AG or ACNP-BC) and those developing educational programs for advanced nursing practice, job descriptions and credentialing, among other uses.
New edition of ACNP Scope and Standard is available from American Association of Critical-Care Nurses (aacn.org).
AACN has published a new edition of “AACN Scope and Standards for Acute Care Nurse Practitioner Practice” to reflect the specialty’s evolving role and an ever-changing critical care landscape.
First issued in 2006 and previously updated in 2012, the new edition describes and measures the expected level of practice and professional performance for acute care nurse practitioners (ACNPs). The 2017 edition, which came from collaboration from a work group of ACNP subject matter experts convened by AACN collaborated to update the content to reflect current practice incorporates advances in scientific knowledge, clinical practice, technology and other changes in the dynamic healthcare environment. It addresses the full scope of practice for ACNPs, including those whose education and training prepare them to care for children with acute and critical illnesses. It also aligns with the “Consensus Model for APRN Regulation” — also called the LACE Model — developed to create national congruence for licensure, accreditation, certification, and education of advanced practice nurses.
“The role of acute care nurse practitioners continues to expand as more hospitals and healthcare organizations discover the value of having ACNPs on staff,” said Linda Bell, AACN clinical practice specialist and editor of the publication. “Patients who used to be hospitalized are now cared for throughout the healthcare system. As a result, the services or care provided by ACNPs and other advanced practice providers are not defined or limited by setting but rather by patient care needs.”
These standards are a valuable resource for acute care pediatric nurse practitioners (CPNP-AC), adult ACNPs (ACNPC-AG or ACNP-BC) and those developing educational programs for advanced nursing practice, job descriptions and credentialing, among other uses.
New edition of ACNP Scope and Standard is available from American Association of Critical-Care Nurses (aacn.org).
AACN has published a new edition of “AACN Scope and Standards for Acute Care Nurse Practitioner Practice” to reflect the specialty’s evolving role and an ever-changing critical care landscape.
First issued in 2006 and previously updated in 2012, the new edition describes and measures the expected level of practice and professional performance for acute care nurse practitioners (ACNPs). The 2017 edition, which came from collaboration from a work group of ACNP subject matter experts convened by AACN collaborated to update the content to reflect current practice incorporates advances in scientific knowledge, clinical practice, technology and other changes in the dynamic healthcare environment. It addresses the full scope of practice for ACNPs, including those whose education and training prepare them to care for children with acute and critical illnesses. It also aligns with the “Consensus Model for APRN Regulation” — also called the LACE Model — developed to create national congruence for licensure, accreditation, certification, and education of advanced practice nurses.
“The role of acute care nurse practitioners continues to expand as more hospitals and healthcare organizations discover the value of having ACNPs on staff,” said Linda Bell, AACN clinical practice specialist and editor of the publication. “Patients who used to be hospitalized are now cared for throughout the healthcare system. As a result, the services or care provided by ACNPs and other advanced practice providers are not defined or limited by setting but rather by patient care needs.”
These standards are a valuable resource for acute care pediatric nurse practitioners (CPNP-AC), adult ACNPs (ACNPC-AG or ACNP-BC) and those developing educational programs for advanced nursing practice, job descriptions and credentialing, among other uses.
New edition of ACNP Scope and Standard is available from American Association of Critical-Care Nurses (aacn.org).
CHEST®, the flagship peer-reviewed journal of the American College of Chest Physicians (CHEST), is seeking applicants for the next Editor in Chief (EIC). President of CHEST, Dr. John Studdard, has given some insight into the successes of the journal during current EIC, Dr. Richard Irwin’s tenure, and what we can expect from the respected individual who will take his place in 2019.
“From my perspective as a community-based physician practicing pulmonary, critical care, and sleep medicine, I believe the responsibility of member-based organizations like CHEST is to ensure that we create meaningful science, create outstanding education, and work to ensure these are disseminated and implemented. One of the most important vehicles that we depend on is our CHEST® journal.
CHEST® is more than just a medical journal; it is the face and brand of the American College of Chest Physicians. Recognition and awareness of the journal as the face of the organization is an incredibly important aspect of what it means to the CHEST organization as a whole.”
Dr. Studdard’s insights as to some of the successes and the future of CHEST®:
Question: What is your view on the successes of the journal over Dr. Irwin’s tenure?
Answer: A. The journal consistently ranks as the #1 relevant journal for respiratory clinicians and providers.
B. The journal’s “impact factor” has increased significantly, which supports its efforts to attract the best clinical research and content.
C. New sections added provide applicable clinical information, address hot and controversial topics, and underscore the human side of medicine to support the best patient-focused care.
D. The continual improvement of our online platform, including development of multimedia content and other innovations that take advantage of the digital evolution of online content delivery.
E. Last, but not least, I believe our members who are clinicians consider CHEST® to be the one journal to review cover to cover and to be their “go to” journal for relevant clinical insights and information.
Question: What challenges does CHEST expect the next EIC to be facing?
Answer: We clearly practice in an environment where there are constant pulls for the time and attention of clinicians … a constant influx of information and education in multiple formats and delivery systems. The journal CHEST® must highlight the information we need most that will impact patient care. Our new EIC, and the team assembled, will need to solicit the best research, continue our digital evolution, and ensure they are delivering this information in the way that our members and learners find the most accessible.Question: Where do “we” want the journal to go?
Answer: Your leadership of the American College of Chest Physicians has great respect for the editorial independence of the journal. The EIC and the Editorial Board that is assembled will lead where the journal goes. As the embodiment of the brand of the CHEST organization, we clearly want to see the journal continue to be the authoritative, respected, trusted, “go to” resource for clinical pulmonary, critical care, and sleep medicine professionals.
CHEST is now accepting applications for the position of Editor in Chief of the CHEST® journal. For more information visit http://info.chestnet.org/editor-in-chief. Applications are due by February 1, 2018.
CHEST®, the flagship peer-reviewed journal of the American College of Chest Physicians (CHEST), is seeking applicants for the next Editor in Chief (EIC). President of CHEST, Dr. John Studdard, has given some insight into the successes of the journal during current EIC, Dr. Richard Irwin’s tenure, and what we can expect from the respected individual who will take his place in 2019.
“From my perspective as a community-based physician practicing pulmonary, critical care, and sleep medicine, I believe the responsibility of member-based organizations like CHEST is to ensure that we create meaningful science, create outstanding education, and work to ensure these are disseminated and implemented. One of the most important vehicles that we depend on is our CHEST® journal.
CHEST® is more than just a medical journal; it is the face and brand of the American College of Chest Physicians. Recognition and awareness of the journal as the face of the organization is an incredibly important aspect of what it means to the CHEST organization as a whole.”
Dr. Studdard’s insights as to some of the successes and the future of CHEST®:
Question: What is your view on the successes of the journal over Dr. Irwin’s tenure?
Answer: A. The journal consistently ranks as the #1 relevant journal for respiratory clinicians and providers.
B. The journal’s “impact factor” has increased significantly, which supports its efforts to attract the best clinical research and content.
C. New sections added provide applicable clinical information, address hot and controversial topics, and underscore the human side of medicine to support the best patient-focused care.
D. The continual improvement of our online platform, including development of multimedia content and other innovations that take advantage of the digital evolution of online content delivery.
E. Last, but not least, I believe our members who are clinicians consider CHEST® to be the one journal to review cover to cover and to be their “go to” journal for relevant clinical insights and information.
Question: What challenges does CHEST expect the next EIC to be facing?
Answer: We clearly practice in an environment where there are constant pulls for the time and attention of clinicians … a constant influx of information and education in multiple formats and delivery systems. The journal CHEST® must highlight the information we need most that will impact patient care. Our new EIC, and the team assembled, will need to solicit the best research, continue our digital evolution, and ensure they are delivering this information in the way that our members and learners find the most accessible.Question: Where do “we” want the journal to go?
Answer: Your leadership of the American College of Chest Physicians has great respect for the editorial independence of the journal. The EIC and the Editorial Board that is assembled will lead where the journal goes. As the embodiment of the brand of the CHEST organization, we clearly want to see the journal continue to be the authoritative, respected, trusted, “go to” resource for clinical pulmonary, critical care, and sleep medicine professionals.
CHEST is now accepting applications for the position of Editor in Chief of the CHEST® journal. For more information visit http://info.chestnet.org/editor-in-chief. Applications are due by February 1, 2018.
CHEST®, the flagship peer-reviewed journal of the American College of Chest Physicians (CHEST), is seeking applicants for the next Editor in Chief (EIC). President of CHEST, Dr. John Studdard, has given some insight into the successes of the journal during current EIC, Dr. Richard Irwin’s tenure, and what we can expect from the respected individual who will take his place in 2019.
“From my perspective as a community-based physician practicing pulmonary, critical care, and sleep medicine, I believe the responsibility of member-based organizations like CHEST is to ensure that we create meaningful science, create outstanding education, and work to ensure these are disseminated and implemented. One of the most important vehicles that we depend on is our CHEST® journal.
CHEST® is more than just a medical journal; it is the face and brand of the American College of Chest Physicians. Recognition and awareness of the journal as the face of the organization is an incredibly important aspect of what it means to the CHEST organization as a whole.”
Dr. Studdard’s insights as to some of the successes and the future of CHEST®:
Question: What is your view on the successes of the journal over Dr. Irwin’s tenure?
Answer: A. The journal consistently ranks as the #1 relevant journal for respiratory clinicians and providers.
B. The journal’s “impact factor” has increased significantly, which supports its efforts to attract the best clinical research and content.
C. New sections added provide applicable clinical information, address hot and controversial topics, and underscore the human side of medicine to support the best patient-focused care.
D. The continual improvement of our online platform, including development of multimedia content and other innovations that take advantage of the digital evolution of online content delivery.
E. Last, but not least, I believe our members who are clinicians consider CHEST® to be the one journal to review cover to cover and to be their “go to” journal for relevant clinical insights and information.
Question: What challenges does CHEST expect the next EIC to be facing?
Answer: We clearly practice in an environment where there are constant pulls for the time and attention of clinicians … a constant influx of information and education in multiple formats and delivery systems. The journal CHEST® must highlight the information we need most that will impact patient care. Our new EIC, and the team assembled, will need to solicit the best research, continue our digital evolution, and ensure they are delivering this information in the way that our members and learners find the most accessible.Question: Where do “we” want the journal to go?
Answer: Your leadership of the American College of Chest Physicians has great respect for the editorial independence of the journal. The EIC and the Editorial Board that is assembled will lead where the journal goes. As the embodiment of the brand of the CHEST organization, we clearly want to see the journal continue to be the authoritative, respected, trusted, “go to” resource for clinical pulmonary, critical care, and sleep medicine professionals.
CHEST is now accepting applications for the position of Editor in Chief of the CHEST® journal. For more information visit http://info.chestnet.org/editor-in-chief. Applications are due by February 1, 2018.
With the great success of CHEST 2017, everyone who shared that event is a winner. But, we would especially like to call out some of the special winners who were recognized during our meeting in Toronto.
CHEST 2017 Awards
College Medalist Award Sidney Braman, MD, Master FCCP
Distinguished Service Award Nancy Collop, MD, FCCP
Master FCCP Suhail Raoof, MD, Master FCCP
Master FCCP Sidney Braman, MD, Master FCCP
Early Career Clinician Educator Septimiu Murgu, MD, FCCP
Alfred Soffer Award for Editorial Excellence Christopher Carroll, MD, FCCPDeep Ramachandran, MBBS
Honor Lectures
Thomas L. Petty, MD, Master FCCP Memorial Lecture Personalized Treatment in COPD: A New Era of Treatment OptionsGerard J. Criner, MD, FCCP
Presidential Honor Lecture Passion, Perseverance, and Quantum Leaps: Major Advances in Lung Cancer CareM. Patricia Rivera, MD, FCCP
Margaret Pfrommer Memorial Lecture in Long-term Mechanical Ventilation When Air becomes BREATH…and a LIFE worth living Audrey King, MA
Distinguished Scientist Honor Lecture in Cardiopulmonary Physiology Sleep, Death and the HeartVirend K. Somers, MD, PhD, FCCP
Pasquale Ciaglia Memorial Lecture in Interventional Medicine Augmented Reality: Getting Real in Procedural EducationCarla R. Lamb, MD, FCCP
Roger C. Bone Memorial Lecture in Critical Care If You’ve Seen One ICU You’ve Seen All ICUs: Evidence-based Recommendations for the Organization of Critical CareGordon D. Rubenfeld, MD, MS
Edward C. Rosenow III, MD, Master FCCP/Master Teacher Honor Lecture “Pills” and the Air PassagesAtul C. Mehta, MBBS, FCCP
Murray Kornfeld Memorial Founders Lecture Trying to Change Clinical Practice: The Barcelona Respiratory Research GroupAntonio Torres Marti, MD, PhD, FCCP
CHEST Foundation Grant Awards
CHEST Foundation Research Grant in Nontuberculous Mycobacteria Keira Cohen, MD
CHEST Foundation and the Alpha-1 Foundation Research Grant in Alpha-1 Antitrypsin Deficiency Diana Crossley, MBChB
CHEST Foundation Research Grant in Asthma Drew Harris, MD
CHEST Foundation Research Grant in Pulmonary Fibrosis Kerri Johannson, MD, MPH
CHEST Foundation Research Grant in Women’s Lung Health Stephen Lapinsky, MBBCh, MS
CHEST Foundation Research Grant in Chronic Obstructive Pulmonary Disease Emmet O’Brien, MBBCh
CHEST Foundation Research Grant in Venous Thromboembolism Christopher Pannucci, MD
CHEST Foundation Research Grant in Cystic Fibrosis Kathleen Ramos, MD, MS
CHEST Foundation Research Grant in Pulmonary Arterial Hypertension Sandeep Sahay, MD, FCCP
CHEST Foundation Research Grant in Lung Cancer Kei Suzuki, MD
GlaxoSmithKline Distinguished Scholar in Respiratory Health Richard Wunderlink, MD, FCCP
CHEST Co-Branded Community Service Initiatives Sandra Adams, MD, MS, FCCP; Mary Hart, RRT, MS, FCCP
GAIN NSCLC Summits Community Service Grant J. Scott Ferguson, MD, FCCP
CHEST Foundation Community Service Grants Honoring D. Robert McCaffree, MD, Master FCCP; Negin Hajizadeh, MD, MPH; Adam Silverman, MD
Case Report Poster Winners
Javier Ramos Rossy, MD
Bikash Bhattarai, MD
Nikita Leiter, MD
Lindsay Boole, MD, MPH
Muhammad Hammami, MD
Jonathan Dewald, MD
Ahmed Mahgoub, MD
Ali Saeed, MD
Aditya Kotecha, MD
David Attalla, MD
CHEST Challenge Winners
San Antonio Military Medical Center
David Anderson, DO
Paul Hiles, MD, BSc
Tyson Sjulin, DO
Alfred Soffer Research Award Winners
Marcos Restrepo, MD, MSc, FCCP: Anti-MRSA Coverage Overutilization as Empiric Therapy for Hospitalized Patients With Community-acquired Pneumonia and Health-care Associated Pneumonia
Michael Perkins, MD: Rothman Index Predicts ICU Mortality at 24 hours
Young Investigator Award Winners
Adam Przebinda, MD: Analysis of a Hospital-based Multimodal Quality Improvement Intervention to Improve Recognition and Treatment of Sepsis
Roozehra Khan, DO, FCCP: Growth in Social Media & Live-Tweeting at Major Critical Care Conferences: Twitter Analysis of Past 4 Years
Top 5 Slide Presentation Winners
Jonathan Corren, MD: Dupilumab Improves Asthma Control and Asthma-Related Quality of Life in Uncontrolled Persistent Asthma Patients Across All Baseline Exacerbation Rates
Aaron B. Holley, MD, FCCP: Heparin prophylaxis does not prevent VTE in the presence of acute kidney injury
Anil Vachani, MD, FCCP: A Blood-based Multi-gene Expression Classifier to Distinguish Benign from Malignant Pulmonary Nodules
Abhishek Mishra, MD: Comparison of Catheter directed thrombolysis vs systemic thrombolysis in pulmonary embolism: A propensity score match analysis
David E. Ost, MD, MPH, FCCP: Comparison of Practice Patterns and Outcomes for Recurrent Malignant Pleural Effusions
Case Report Slide Winners
Christian Castaneda, MD: Levofloxacin-Induced Acute Eosinophilic Pneumonitis: A Case Report And Review
Lucian Marts, MD: The Proof Is In The Platelets
Fuad Aleskerov, MD: Disseminated Resistant Nocardiosis In Previously Healthy Male
Taylor Myers, MD: Spontaneous Regression Of Non-Small Cell Lung Cancer
Amin Pasha, MD: Is Fat Always Bad? A Case Study Demonstrating The Lifesaving Effect Of Lipid Emulsion Therapy In Beta Blocker And Calcium Channel Blocker Overdose
Anish Geevarghese, MD: The Use Of Venovenous-ECMO For Refractory Hypoxemia Following Liver Transplantation In A Patient With Hepatopulmonary Syndrome
Juilio Huapaya, MD: Hemophagocytic Lymphohistiocytosis Induced By Histoplasmosis In A Kidney Transplant Patient: Are Steroids Really Necessary?
Stephen Doyle, DO, MBA: Diffuse Pulmonary Nodules: A Rare Infection Causing A Common Problem
Catherine Millender, MD: An Intriguing Case Of Recurrent Bilateral Massive Chylothoraces: Is This Pleural Sarcoidosis?
Andrew Lewis, DO: Transformation Of Benign Metastasizing Leiomyoma (BML) To Leiomyosarcoma
With the great success of CHEST 2017, everyone who shared that event is a winner. But, we would especially like to call out some of the special winners who were recognized during our meeting in Toronto.
CHEST 2017 Awards
College Medalist Award Sidney Braman, MD, Master FCCP
Distinguished Service Award Nancy Collop, MD, FCCP
Master FCCP Suhail Raoof, MD, Master FCCP
Master FCCP Sidney Braman, MD, Master FCCP
Early Career Clinician Educator Septimiu Murgu, MD, FCCP
Alfred Soffer Award for Editorial Excellence Christopher Carroll, MD, FCCPDeep Ramachandran, MBBS
Honor Lectures
Thomas L. Petty, MD, Master FCCP Memorial Lecture Personalized Treatment in COPD: A New Era of Treatment OptionsGerard J. Criner, MD, FCCP
Presidential Honor Lecture Passion, Perseverance, and Quantum Leaps: Major Advances in Lung Cancer CareM. Patricia Rivera, MD, FCCP
Margaret Pfrommer Memorial Lecture in Long-term Mechanical Ventilation When Air becomes BREATH…and a LIFE worth living Audrey King, MA
Distinguished Scientist Honor Lecture in Cardiopulmonary Physiology Sleep, Death and the HeartVirend K. Somers, MD, PhD, FCCP
Pasquale Ciaglia Memorial Lecture in Interventional Medicine Augmented Reality: Getting Real in Procedural EducationCarla R. Lamb, MD, FCCP
Roger C. Bone Memorial Lecture in Critical Care If You’ve Seen One ICU You’ve Seen All ICUs: Evidence-based Recommendations for the Organization of Critical CareGordon D. Rubenfeld, MD, MS
Edward C. Rosenow III, MD, Master FCCP/Master Teacher Honor Lecture “Pills” and the Air PassagesAtul C. Mehta, MBBS, FCCP
Murray Kornfeld Memorial Founders Lecture Trying to Change Clinical Practice: The Barcelona Respiratory Research GroupAntonio Torres Marti, MD, PhD, FCCP
CHEST Foundation Grant Awards
CHEST Foundation Research Grant in Nontuberculous Mycobacteria Keira Cohen, MD
CHEST Foundation and the Alpha-1 Foundation Research Grant in Alpha-1 Antitrypsin Deficiency Diana Crossley, MBChB
CHEST Foundation Research Grant in Asthma Drew Harris, MD
CHEST Foundation Research Grant in Pulmonary Fibrosis Kerri Johannson, MD, MPH
CHEST Foundation Research Grant in Women’s Lung Health Stephen Lapinsky, MBBCh, MS
CHEST Foundation Research Grant in Chronic Obstructive Pulmonary Disease Emmet O’Brien, MBBCh
CHEST Foundation Research Grant in Venous Thromboembolism Christopher Pannucci, MD
CHEST Foundation Research Grant in Cystic Fibrosis Kathleen Ramos, MD, MS
CHEST Foundation Research Grant in Pulmonary Arterial Hypertension Sandeep Sahay, MD, FCCP
CHEST Foundation Research Grant in Lung Cancer Kei Suzuki, MD
GlaxoSmithKline Distinguished Scholar in Respiratory Health Richard Wunderlink, MD, FCCP
CHEST Co-Branded Community Service Initiatives Sandra Adams, MD, MS, FCCP; Mary Hart, RRT, MS, FCCP
GAIN NSCLC Summits Community Service Grant J. Scott Ferguson, MD, FCCP
CHEST Foundation Community Service Grants Honoring D. Robert McCaffree, MD, Master FCCP; Negin Hajizadeh, MD, MPH; Adam Silverman, MD
Case Report Poster Winners
Javier Ramos Rossy, MD
Bikash Bhattarai, MD
Nikita Leiter, MD
Lindsay Boole, MD, MPH
Muhammad Hammami, MD
Jonathan Dewald, MD
Ahmed Mahgoub, MD
Ali Saeed, MD
Aditya Kotecha, MD
David Attalla, MD
CHEST Challenge Winners
San Antonio Military Medical Center
David Anderson, DO
Paul Hiles, MD, BSc
Tyson Sjulin, DO
Alfred Soffer Research Award Winners
Marcos Restrepo, MD, MSc, FCCP: Anti-MRSA Coverage Overutilization as Empiric Therapy for Hospitalized Patients With Community-acquired Pneumonia and Health-care Associated Pneumonia
Michael Perkins, MD: Rothman Index Predicts ICU Mortality at 24 hours
Young Investigator Award Winners
Adam Przebinda, MD: Analysis of a Hospital-based Multimodal Quality Improvement Intervention to Improve Recognition and Treatment of Sepsis
Roozehra Khan, DO, FCCP: Growth in Social Media & Live-Tweeting at Major Critical Care Conferences: Twitter Analysis of Past 4 Years
Top 5 Slide Presentation Winners
Jonathan Corren, MD: Dupilumab Improves Asthma Control and Asthma-Related Quality of Life in Uncontrolled Persistent Asthma Patients Across All Baseline Exacerbation Rates
Aaron B. Holley, MD, FCCP: Heparin prophylaxis does not prevent VTE in the presence of acute kidney injury
Anil Vachani, MD, FCCP: A Blood-based Multi-gene Expression Classifier to Distinguish Benign from Malignant Pulmonary Nodules
Abhishek Mishra, MD: Comparison of Catheter directed thrombolysis vs systemic thrombolysis in pulmonary embolism: A propensity score match analysis
David E. Ost, MD, MPH, FCCP: Comparison of Practice Patterns and Outcomes for Recurrent Malignant Pleural Effusions
Case Report Slide Winners
Christian Castaneda, MD: Levofloxacin-Induced Acute Eosinophilic Pneumonitis: A Case Report And Review
Lucian Marts, MD: The Proof Is In The Platelets
Fuad Aleskerov, MD: Disseminated Resistant Nocardiosis In Previously Healthy Male
Taylor Myers, MD: Spontaneous Regression Of Non-Small Cell Lung Cancer
Amin Pasha, MD: Is Fat Always Bad? A Case Study Demonstrating The Lifesaving Effect Of Lipid Emulsion Therapy In Beta Blocker And Calcium Channel Blocker Overdose
Anish Geevarghese, MD: The Use Of Venovenous-ECMO For Refractory Hypoxemia Following Liver Transplantation In A Patient With Hepatopulmonary Syndrome
Juilio Huapaya, MD: Hemophagocytic Lymphohistiocytosis Induced By Histoplasmosis In A Kidney Transplant Patient: Are Steroids Really Necessary?
Stephen Doyle, DO, MBA: Diffuse Pulmonary Nodules: A Rare Infection Causing A Common Problem
Catherine Millender, MD: An Intriguing Case Of Recurrent Bilateral Massive Chylothoraces: Is This Pleural Sarcoidosis?
Andrew Lewis, DO: Transformation Of Benign Metastasizing Leiomyoma (BML) To Leiomyosarcoma
Lana Alghothani, MD: Idiopathic Pneumonia Syndrome In Patient With Gray Zone Lymphoma Successfully Treated With Etanercept
Aaron Lampkin, MD: These Aren’t The Paraproteins You Have Been Looking For: A Case Of Light Chain Deposition Disease
Tyler Church: His Heart Was Three Sizes Too Smallpox
Ki-Yoon Kim, MD: Coma Secondary To Rickettsia Typhi
Nicole Ruopp, MD: Epoprostenol And Ascites: A High Output State Or Not?
Stephanie Guo, MD: Neuroendocrine Cells And A Spectrum Of Disease
Justin Chiam, MBBS: A Diagnostic Challenge Of Haemoptysis In A TB Endemic Southeast Asian Country
NetWork Challenge Winners
First Round: Home-Based Mechanical Ventilation and Neuromuscular Disease NetWork, and Women’s Health NetWork
Second Round:Home-Based Mechanical Ventilation and Neuromuscular Disease and Practice Operations
Third Round: Home-Based Mechanical Ventilation and Neuromuscular Disease and Practice Operations
With the great success of CHEST 2017, everyone who shared that event is a winner. But, we would especially like to call out some of the special winners who were recognized during our meeting in Toronto.
CHEST 2017 Awards
College Medalist Award Sidney Braman, MD, Master FCCP
Distinguished Service Award Nancy Collop, MD, FCCP
Master FCCP Suhail Raoof, MD, Master FCCP
Master FCCP Sidney Braman, MD, Master FCCP
Early Career Clinician Educator Septimiu Murgu, MD, FCCP
Alfred Soffer Award for Editorial Excellence Christopher Carroll, MD, FCCPDeep Ramachandran, MBBS
Honor Lectures
Thomas L. Petty, MD, Master FCCP Memorial Lecture Personalized Treatment in COPD: A New Era of Treatment OptionsGerard J. Criner, MD, FCCP
Presidential Honor Lecture Passion, Perseverance, and Quantum Leaps: Major Advances in Lung Cancer CareM. Patricia Rivera, MD, FCCP
Margaret Pfrommer Memorial Lecture in Long-term Mechanical Ventilation When Air becomes BREATH…and a LIFE worth living Audrey King, MA
Distinguished Scientist Honor Lecture in Cardiopulmonary Physiology Sleep, Death and the HeartVirend K. Somers, MD, PhD, FCCP
Pasquale Ciaglia Memorial Lecture in Interventional Medicine Augmented Reality: Getting Real in Procedural EducationCarla R. Lamb, MD, FCCP
Roger C. Bone Memorial Lecture in Critical Care If You’ve Seen One ICU You’ve Seen All ICUs: Evidence-based Recommendations for the Organization of Critical CareGordon D. Rubenfeld, MD, MS
Edward C. Rosenow III, MD, Master FCCP/Master Teacher Honor Lecture “Pills” and the Air PassagesAtul C. Mehta, MBBS, FCCP
Murray Kornfeld Memorial Founders Lecture Trying to Change Clinical Practice: The Barcelona Respiratory Research GroupAntonio Torres Marti, MD, PhD, FCCP
CHEST Foundation Grant Awards
CHEST Foundation Research Grant in Nontuberculous Mycobacteria Keira Cohen, MD
CHEST Foundation and the Alpha-1 Foundation Research Grant in Alpha-1 Antitrypsin Deficiency Diana Crossley, MBChB
CHEST Foundation Research Grant in Asthma Drew Harris, MD
CHEST Foundation Research Grant in Pulmonary Fibrosis Kerri Johannson, MD, MPH
CHEST Foundation Research Grant in Women’s Lung Health Stephen Lapinsky, MBBCh, MS
CHEST Foundation Research Grant in Chronic Obstructive Pulmonary Disease Emmet O’Brien, MBBCh
CHEST Foundation Research Grant in Venous Thromboembolism Christopher Pannucci, MD
CHEST Foundation Research Grant in Cystic Fibrosis Kathleen Ramos, MD, MS
CHEST Foundation Research Grant in Pulmonary Arterial Hypertension Sandeep Sahay, MD, FCCP
CHEST Foundation Research Grant in Lung Cancer Kei Suzuki, MD
GlaxoSmithKline Distinguished Scholar in Respiratory Health Richard Wunderlink, MD, FCCP
CHEST Co-Branded Community Service Initiatives Sandra Adams, MD, MS, FCCP; Mary Hart, RRT, MS, FCCP
GAIN NSCLC Summits Community Service Grant J. Scott Ferguson, MD, FCCP
CHEST Foundation Community Service Grants Honoring D. Robert McCaffree, MD, Master FCCP; Negin Hajizadeh, MD, MPH; Adam Silverman, MD
Case Report Poster Winners
Javier Ramos Rossy, MD
Bikash Bhattarai, MD
Nikita Leiter, MD
Lindsay Boole, MD, MPH
Muhammad Hammami, MD
Jonathan Dewald, MD
Ahmed Mahgoub, MD
Ali Saeed, MD
Aditya Kotecha, MD
David Attalla, MD
CHEST Challenge Winners
San Antonio Military Medical Center
David Anderson, DO
Paul Hiles, MD, BSc
Tyson Sjulin, DO
Alfred Soffer Research Award Winners
Marcos Restrepo, MD, MSc, FCCP: Anti-MRSA Coverage Overutilization as Empiric Therapy for Hospitalized Patients With Community-acquired Pneumonia and Health-care Associated Pneumonia
Michael Perkins, MD: Rothman Index Predicts ICU Mortality at 24 hours
Young Investigator Award Winners
Adam Przebinda, MD: Analysis of a Hospital-based Multimodal Quality Improvement Intervention to Improve Recognition and Treatment of Sepsis
Roozehra Khan, DO, FCCP: Growth in Social Media & Live-Tweeting at Major Critical Care Conferences: Twitter Analysis of Past 4 Years
Top 5 Slide Presentation Winners
Jonathan Corren, MD: Dupilumab Improves Asthma Control and Asthma-Related Quality of Life in Uncontrolled Persistent Asthma Patients Across All Baseline Exacerbation Rates
Aaron B. Holley, MD, FCCP: Heparin prophylaxis does not prevent VTE in the presence of acute kidney injury
Anil Vachani, MD, FCCP: A Blood-based Multi-gene Expression Classifier to Distinguish Benign from Malignant Pulmonary Nodules
Abhishek Mishra, MD: Comparison of Catheter directed thrombolysis vs systemic thrombolysis in pulmonary embolism: A propensity score match analysis
David E. Ost, MD, MPH, FCCP: Comparison of Practice Patterns and Outcomes for Recurrent Malignant Pleural Effusions
Case Report Slide Winners
Christian Castaneda, MD: Levofloxacin-Induced Acute Eosinophilic Pneumonitis: A Case Report And Review
Lucian Marts, MD: The Proof Is In The Platelets
Fuad Aleskerov, MD: Disseminated Resistant Nocardiosis In Previously Healthy Male
Taylor Myers, MD: Spontaneous Regression Of Non-Small Cell Lung Cancer
Amin Pasha, MD: Is Fat Always Bad? A Case Study Demonstrating The Lifesaving Effect Of Lipid Emulsion Therapy In Beta Blocker And Calcium Channel Blocker Overdose
Anish Geevarghese, MD: The Use Of Venovenous-ECMO For Refractory Hypoxemia Following Liver Transplantation In A Patient With Hepatopulmonary Syndrome
Juilio Huapaya, MD: Hemophagocytic Lymphohistiocytosis Induced By Histoplasmosis In A Kidney Transplant Patient: Are Steroids Really Necessary?
Stephen Doyle, DO, MBA: Diffuse Pulmonary Nodules: A Rare Infection Causing A Common Problem
Catherine Millender, MD: An Intriguing Case Of Recurrent Bilateral Massive Chylothoraces: Is This Pleural Sarcoidosis?
Andrew Lewis, DO: Transformation Of Benign Metastasizing Leiomyoma (BML) To Leiomyosarcoma
Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info and Research Patient Survey and the Bronchiectasis and NTM Research Registry.
By Dr. E. Henkle, et al.
Totally Implantable Intravenous Treprostinil Therapy in Pulmonary Hypertension: Assessment of the Implantation Procedure.
By Dr. A. Lautenbach, et al.
Commentary
Crotalaria (Monocrotaline) Pulmonary Hypertension: The Fiftieth Anniversary.
Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info and Research Patient Survey and the Bronchiectasis and NTM Research Registry.
By Dr. E. Henkle, et al.
Totally Implantable Intravenous Treprostinil Therapy in Pulmonary Hypertension: Assessment of the Implantation Procedure.
By Dr. A. Lautenbach, et al.
Commentary
Crotalaria (Monocrotaline) Pulmonary Hypertension: The Fiftieth Anniversary.
By Dr. J. Kay.
Original Research
Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info and Research Patient Survey and the Bronchiectasis and NTM Research Registry.
By Dr. E. Henkle, et al.
Totally Implantable Intravenous Treprostinil Therapy in Pulmonary Hypertension: Assessment of the Implantation Procedure.
By Dr. A. Lautenbach, et al.
Commentary
Crotalaria (Monocrotaline) Pulmonary Hypertension: The Fiftieth Anniversary.
In mid-September, NAMDRC, along with the American Thoracic Society, the American Association for Respiratory Care, the COPD Foundation, the American Lung Association, and others met to discuss the components of a legislative agenda for the coming years. The primary purpose behind the meeting was the premise that IF the current Republican majority would shift in either the House or Senate after the 2018 election, the community should be prepared to move an already agreed upon legislative agenda. CHEST was involved in the preliminary discussions, as well as follow-up, but was not in attendance at the meeting due to a scheduling conflict. There was also tacit agreement that as these policies are fleshed out and crafted into specific legislative language, the community would re-evaluate the current political climate to determine the value of pushing an agreed upon agenda prior to the 2018 elections.
Various patient groups were also invited to participate, but scheduling conflicts precluded some societies from participating but signaled their desire to work with the broad pulmonary medicine community to pursue common goals.
Phil Porte
Each society brought its legislative priorities to the table, and there was active discussion on issues ranging from funding for NIH/NHLBI, to CDC and its COPD Action Plan, to a range of Medicare-related issues.
NAMDRC brought three specific Medicare coverage and payment issues to the discussion: home mechanical ventilation, payment for high flow oxygen therapy, and site of service/Section 603 issues.
Home mechanical ventilation is admittedly a complex issue, but it is moving forward in at least two political directions. First, Senator Bill Cassidy (R-LA) and a physician by training, has signaled his desire to move this issue forward, either legislatively or giving CMS one last chance to move forward through the regulatory structure. He agrees that a payment system that inhibits access to appropriate bi-level mechanical ventilators and encourages access to more complex life-sustaining ventilators, regardless of documented medical need, is appropriate. While CMS does have the authority to act, it has chosen to ignore repeated requests for action over the past 4 years.
Ironically, the House Energy and Commerce Committee, which shares jurisdiction on the House of Representatives with the Ways and Means Committee on Medicare issues, has sent a request to the Congressional Budget Office to provide a cost estimate (a “score” in Washington vernacular) of likely savings from a legislative solution to this matter. In the current political climate, a legislative proposal that actually saves $$$ is politically attractive, and we are working both the regulatory and legislative pathway to seek a workable solution.
On the oxygen therapy issue, there is growing evidence that, for a small group of Medicare beneficiaries who need high flow oxygen therapy as their disease progresses (pulmonary fibrosis, end-stage COPD, etc), there are no oxygen systems readily available to meet that need outside the home. At home, numerous concentrators can meet that need, but outside the home, the ideal solution, liquid systems, is not readily available because of the payment system tied to competitive bidding. CMS payment data indicate that a very low percentage of oxygen users need more than 4 liters per minute, and current law would make a payment adjustment unique to certain patients a very difficult hurdle, particularly in the era of competitive bidding, a legislative change is the best solution facing the community. The challenge is to craft legislative language that addresses the need but would preclude abuse by suppliers who might jump at the chance for higher payment for liquid, well above current payment levels. And because liquid systems fit into a “delivery model” business plan, contrary to portable oxygen concentrators and transfill systems, the solution is not as easy as a payment bump to make provision of liquid systems more attractive.
Site of service regulations are hitting pulmonary rehabilitation particularly hard, and CMS concedes that the only solution is a legislative one. Under current policy, a pulmonary rehab program that is located off campus but needs to expand or move from its current location (losing a lease, for example), if the expanded program is NOT within 250 yards of the main hospital campus, the program is then reimbursed at the physician fee schedule rate, a rate cut of approximately 50%. Needless to say, hospitals are not pursuing that approach. Likewise, a hospital that chooses to open a NEW program is also constrained, needing to locate within 250 yards of the main campus or face the dramatic cut in payment.
As these issues evolve and the political climate perhaps opens unique opportunities, we can expect the broad pulmonary community to pursue these and other issues.
In mid-September, NAMDRC, along with the American Thoracic Society, the American Association for Respiratory Care, the COPD Foundation, the American Lung Association, and others met to discuss the components of a legislative agenda for the coming years. The primary purpose behind the meeting was the premise that IF the current Republican majority would shift in either the House or Senate after the 2018 election, the community should be prepared to move an already agreed upon legislative agenda. CHEST was involved in the preliminary discussions, as well as follow-up, but was not in attendance at the meeting due to a scheduling conflict. There was also tacit agreement that as these policies are fleshed out and crafted into specific legislative language, the community would re-evaluate the current political climate to determine the value of pushing an agreed upon agenda prior to the 2018 elections.
Various patient groups were also invited to participate, but scheduling conflicts precluded some societies from participating but signaled their desire to work with the broad pulmonary medicine community to pursue common goals.
Phil Porte
Each society brought its legislative priorities to the table, and there was active discussion on issues ranging from funding for NIH/NHLBI, to CDC and its COPD Action Plan, to a range of Medicare-related issues.
NAMDRC brought three specific Medicare coverage and payment issues to the discussion: home mechanical ventilation, payment for high flow oxygen therapy, and site of service/Section 603 issues.
Home mechanical ventilation is admittedly a complex issue, but it is moving forward in at least two political directions. First, Senator Bill Cassidy (R-LA) and a physician by training, has signaled his desire to move this issue forward, either legislatively or giving CMS one last chance to move forward through the regulatory structure. He agrees that a payment system that inhibits access to appropriate bi-level mechanical ventilators and encourages access to more complex life-sustaining ventilators, regardless of documented medical need, is appropriate. While CMS does have the authority to act, it has chosen to ignore repeated requests for action over the past 4 years.
Ironically, the House Energy and Commerce Committee, which shares jurisdiction on the House of Representatives with the Ways and Means Committee on Medicare issues, has sent a request to the Congressional Budget Office to provide a cost estimate (a “score” in Washington vernacular) of likely savings from a legislative solution to this matter. In the current political climate, a legislative proposal that actually saves $$$ is politically attractive, and we are working both the regulatory and legislative pathway to seek a workable solution.
On the oxygen therapy issue, there is growing evidence that, for a small group of Medicare beneficiaries who need high flow oxygen therapy as their disease progresses (pulmonary fibrosis, end-stage COPD, etc), there are no oxygen systems readily available to meet that need outside the home. At home, numerous concentrators can meet that need, but outside the home, the ideal solution, liquid systems, is not readily available because of the payment system tied to competitive bidding. CMS payment data indicate that a very low percentage of oxygen users need more than 4 liters per minute, and current law would make a payment adjustment unique to certain patients a very difficult hurdle, particularly in the era of competitive bidding, a legislative change is the best solution facing the community. The challenge is to craft legislative language that addresses the need but would preclude abuse by suppliers who might jump at the chance for higher payment for liquid, well above current payment levels. And because liquid systems fit into a “delivery model” business plan, contrary to portable oxygen concentrators and transfill systems, the solution is not as easy as a payment bump to make provision of liquid systems more attractive.
Site of service regulations are hitting pulmonary rehabilitation particularly hard, and CMS concedes that the only solution is a legislative one. Under current policy, a pulmonary rehab program that is located off campus but needs to expand or move from its current location (losing a lease, for example), if the expanded program is NOT within 250 yards of the main hospital campus, the program is then reimbursed at the physician fee schedule rate, a rate cut of approximately 50%. Needless to say, hospitals are not pursuing that approach. Likewise, a hospital that chooses to open a NEW program is also constrained, needing to locate within 250 yards of the main campus or face the dramatic cut in payment.
As these issues evolve and the political climate perhaps opens unique opportunities, we can expect the broad pulmonary community to pursue these and other issues.
In mid-September, NAMDRC, along with the American Thoracic Society, the American Association for Respiratory Care, the COPD Foundation, the American Lung Association, and others met to discuss the components of a legislative agenda for the coming years. The primary purpose behind the meeting was the premise that IF the current Republican majority would shift in either the House or Senate after the 2018 election, the community should be prepared to move an already agreed upon legislative agenda. CHEST was involved in the preliminary discussions, as well as follow-up, but was not in attendance at the meeting due to a scheduling conflict. There was also tacit agreement that as these policies are fleshed out and crafted into specific legislative language, the community would re-evaluate the current political climate to determine the value of pushing an agreed upon agenda prior to the 2018 elections.
Various patient groups were also invited to participate, but scheduling conflicts precluded some societies from participating but signaled their desire to work with the broad pulmonary medicine community to pursue common goals.
Phil Porte
Each society brought its legislative priorities to the table, and there was active discussion on issues ranging from funding for NIH/NHLBI, to CDC and its COPD Action Plan, to a range of Medicare-related issues.
NAMDRC brought three specific Medicare coverage and payment issues to the discussion: home mechanical ventilation, payment for high flow oxygen therapy, and site of service/Section 603 issues.
Home mechanical ventilation is admittedly a complex issue, but it is moving forward in at least two political directions. First, Senator Bill Cassidy (R-LA) and a physician by training, has signaled his desire to move this issue forward, either legislatively or giving CMS one last chance to move forward through the regulatory structure. He agrees that a payment system that inhibits access to appropriate bi-level mechanical ventilators and encourages access to more complex life-sustaining ventilators, regardless of documented medical need, is appropriate. While CMS does have the authority to act, it has chosen to ignore repeated requests for action over the past 4 years.
Ironically, the House Energy and Commerce Committee, which shares jurisdiction on the House of Representatives with the Ways and Means Committee on Medicare issues, has sent a request to the Congressional Budget Office to provide a cost estimate (a “score” in Washington vernacular) of likely savings from a legislative solution to this matter. In the current political climate, a legislative proposal that actually saves $$$ is politically attractive, and we are working both the regulatory and legislative pathway to seek a workable solution.
On the oxygen therapy issue, there is growing evidence that, for a small group of Medicare beneficiaries who need high flow oxygen therapy as their disease progresses (pulmonary fibrosis, end-stage COPD, etc), there are no oxygen systems readily available to meet that need outside the home. At home, numerous concentrators can meet that need, but outside the home, the ideal solution, liquid systems, is not readily available because of the payment system tied to competitive bidding. CMS payment data indicate that a very low percentage of oxygen users need more than 4 liters per minute, and current law would make a payment adjustment unique to certain patients a very difficult hurdle, particularly in the era of competitive bidding, a legislative change is the best solution facing the community. The challenge is to craft legislative language that addresses the need but would preclude abuse by suppliers who might jump at the chance for higher payment for liquid, well above current payment levels. And because liquid systems fit into a “delivery model” business plan, contrary to portable oxygen concentrators and transfill systems, the solution is not as easy as a payment bump to make provision of liquid systems more attractive.
Site of service regulations are hitting pulmonary rehabilitation particularly hard, and CMS concedes that the only solution is a legislative one. Under current policy, a pulmonary rehab program that is located off campus but needs to expand or move from its current location (losing a lease, for example), if the expanded program is NOT within 250 yards of the main hospital campus, the program is then reimbursed at the physician fee schedule rate, a rate cut of approximately 50%. Needless to say, hospitals are not pursuing that approach. Likewise, a hospital that chooses to open a NEW program is also constrained, needing to locate within 250 yards of the main campus or face the dramatic cut in payment.
As these issues evolve and the political climate perhaps opens unique opportunities, we can expect the broad pulmonary community to pursue these and other issues.
Champion…. You ARE A CHAMPION for your patients, and as a CHEST Foundation supporter, you are a Champion for Lung Health! These words are now staples in our foundation mission. To champion lung health through clinical research and community service grants, patient education, and community service, the impact your support can have is quite profound. You are a part of an elite group to be called “champions,” and you should be celebrated for all the ways that you have championed lung health in 2017.
YOU funded more than a half-million dollars in community service grants awarded to the next generation of CHEST leaders.
YOU educated MILLIONS by supporting nationwide disease awareness campaigns for COPD, asthma, sarcoidosis, and lung cancer.
YOU brought the Lung Health Experience to communities where over 1,000 people received COPD and asthma education, as well as spirometry screening.
YOU created awareness in rare disease spaces and raised crucial support by partnering with family foundations, such as the Irv Family Foundation.
The reach of these activities in 2017 has been astounding, and YOU, as a champion for lung health, have generated a great impact on the chest medicine community and the patients we serve.
Now, the CHEST Foundation asks YOU to join us and support our efforts for 2018 by giving to the CHEST Foundation Annual Fund today. We ask you to help:
Meet our fundraising goal of $700,000 for new clinical research and community service grants.
Support NEW lung health disease awareness campaigns.
Expand family foundation partnerships to create NEW patient resources.
Provide NEW e-learning modules to aide patients and caregivers in managing health.
Your support today makes possible tomorrow’s advances in lung health and chest medicine. YOU believe in patient outcomes and, for that commitment, we graciously thank you. YOU save lives by supporting clinical research, patient education, and community service.
Be THE Champion for Lung Health that patients and families count on, and make an impact today. YOU can be a champion and DONATE today through a new gift to the CHEST Foundation. We cannot meet our goals for the health professionals, patients, families, and caregivers we serve without you.
Champion…. You ARE A CHAMPION for your patients, and as a CHEST Foundation supporter, you are a Champion for Lung Health! These words are now staples in our foundation mission. To champion lung health through clinical research and community service grants, patient education, and community service, the impact your support can have is quite profound. You are a part of an elite group to be called “champions,” and you should be celebrated for all the ways that you have championed lung health in 2017.
YOU funded more than a half-million dollars in community service grants awarded to the next generation of CHEST leaders.
YOU educated MILLIONS by supporting nationwide disease awareness campaigns for COPD, asthma, sarcoidosis, and lung cancer.
YOU brought the Lung Health Experience to communities where over 1,000 people received COPD and asthma education, as well as spirometry screening.
YOU created awareness in rare disease spaces and raised crucial support by partnering with family foundations, such as the Irv Family Foundation.
The reach of these activities in 2017 has been astounding, and YOU, as a champion for lung health, have generated a great impact on the chest medicine community and the patients we serve.
Now, the CHEST Foundation asks YOU to join us and support our efforts for 2018 by giving to the CHEST Foundation Annual Fund today. We ask you to help:
Meet our fundraising goal of $700,000 for new clinical research and community service grants.
Support NEW lung health disease awareness campaigns.
Expand family foundation partnerships to create NEW patient resources.
Provide NEW e-learning modules to aide patients and caregivers in managing health.
Your support today makes possible tomorrow’s advances in lung health and chest medicine. YOU believe in patient outcomes and, for that commitment, we graciously thank you. YOU save lives by supporting clinical research, patient education, and community service.
Be THE Champion for Lung Health that patients and families count on, and make an impact today. YOU can be a champion and DONATE today through a new gift to the CHEST Foundation. We cannot meet our goals for the health professionals, patients, families, and caregivers we serve without you.
Thank you for your essential continued support!
Champion…. You ARE A CHAMPION for your patients, and as a CHEST Foundation supporter, you are a Champion for Lung Health! These words are now staples in our foundation mission. To champion lung health through clinical research and community service grants, patient education, and community service, the impact your support can have is quite profound. You are a part of an elite group to be called “champions,” and you should be celebrated for all the ways that you have championed lung health in 2017.
YOU funded more than a half-million dollars in community service grants awarded to the next generation of CHEST leaders.
YOU educated MILLIONS by supporting nationwide disease awareness campaigns for COPD, asthma, sarcoidosis, and lung cancer.
YOU brought the Lung Health Experience to communities where over 1,000 people received COPD and asthma education, as well as spirometry screening.
YOU created awareness in rare disease spaces and raised crucial support by partnering with family foundations, such as the Irv Family Foundation.
The reach of these activities in 2017 has been astounding, and YOU, as a champion for lung health, have generated a great impact on the chest medicine community and the patients we serve.
Now, the CHEST Foundation asks YOU to join us and support our efforts for 2018 by giving to the CHEST Foundation Annual Fund today. We ask you to help:
Meet our fundraising goal of $700,000 for new clinical research and community service grants.
Support NEW lung health disease awareness campaigns.
Expand family foundation partnerships to create NEW patient resources.
Provide NEW e-learning modules to aide patients and caregivers in managing health.
Your support today makes possible tomorrow’s advances in lung health and chest medicine. YOU believe in patient outcomes and, for that commitment, we graciously thank you. YOU save lives by supporting clinical research, patient education, and community service.
Be THE Champion for Lung Health that patients and families count on, and make an impact today. YOU can be a champion and DONATE today through a new gift to the CHEST Foundation. We cannot meet our goals for the health professionals, patients, families, and caregivers we serve without you.
1. You funded more than a half-million dollars in community service and clinical research grants awarded to the next generation of CHEST leaders.
2. You improved patient outcomes by supporting more than 65 patient education resources focused on procedures and disease states—easily accessed for free at chestfoundation.org/patienteducation.
3. You brought the Lung Health Experience to local communities, where more than 1,000 people received free COPD screening and spirometry testing.
4. You raised nearly $200,000 at the Irv Feldman Texas Hold’em and Casino Night to create new patient resources for pulmonary fibrosis.
5. You influenced the careers of 40 young professionals through travel grants and mentorship programs for CHEST Annual Meeting 2017.
6. You educated millions by supporting nationwide disease awareness campaigns for COPD, asthma, sarcoidosis, and lung cancer.
7. You funded asthma training sessions for community-based asthma educators.
8. You supplied physicians in Tanzania pulmonary reference textbooks so that they can learn to do bronchoscopy for the first time.
9. You translated nearly 50 critical care course manuals into French to help Haitian pediatricians save children’s lives.
10. You’re supporting an asthma app that will teach patients how to use their asthma devices.
Thank you for being a champion for lung health. You make this and so much more possible.
1. You funded more than a half-million dollars in community service and clinical research grants awarded to the next generation of CHEST leaders.
2. You improved patient outcomes by supporting more than 65 patient education resources focused on procedures and disease states—easily accessed for free at chestfoundation.org/patienteducation.
3. You brought the Lung Health Experience to local communities, where more than 1,000 people received free COPD screening and spirometry testing.
4. You raised nearly $200,000 at the Irv Feldman Texas Hold’em and Casino Night to create new patient resources for pulmonary fibrosis.
5. You influenced the careers of 40 young professionals through travel grants and mentorship programs for CHEST Annual Meeting 2017.
6. You educated millions by supporting nationwide disease awareness campaigns for COPD, asthma, sarcoidosis, and lung cancer.
7. You funded asthma training sessions for community-based asthma educators.
8. You supplied physicians in Tanzania pulmonary reference textbooks so that they can learn to do bronchoscopy for the first time.
9. You translated nearly 50 critical care course manuals into French to help Haitian pediatricians save children’s lives.
10. You’re supporting an asthma app that will teach patients how to use their asthma devices.
Thank you for being a champion for lung health. You make this and so much more possible.
1. You funded more than a half-million dollars in community service and clinical research grants awarded to the next generation of CHEST leaders.
2. You improved patient outcomes by supporting more than 65 patient education resources focused on procedures and disease states—easily accessed for free at chestfoundation.org/patienteducation.
3. You brought the Lung Health Experience to local communities, where more than 1,000 people received free COPD screening and spirometry testing.
4. You raised nearly $200,000 at the Irv Feldman Texas Hold’em and Casino Night to create new patient resources for pulmonary fibrosis.
5. You influenced the careers of 40 young professionals through travel grants and mentorship programs for CHEST Annual Meeting 2017.
6. You educated millions by supporting nationwide disease awareness campaigns for COPD, asthma, sarcoidosis, and lung cancer.
7. You funded asthma training sessions for community-based asthma educators.
8. You supplied physicians in Tanzania pulmonary reference textbooks so that they can learn to do bronchoscopy for the first time.
9. You translated nearly 50 critical care course manuals into French to help Haitian pediatricians save children’s lives.
10. You’re supporting an asthma app that will teach patients how to use their asthma devices.
Thank you for being a champion for lung health. You make this and so much more possible.
In 2015, Debasree Banerjee, MD, MS, received the CHEST Foundation Research Grant in Pulmonary Arterial Hypertension. She was also a 2016 NetWorks Challenge Travel Grantee as a member of the Women’s Health NetWork, allowing her to attend the 2016 CHEST Annual Meeting and network with peers and leaders in chest medicine. Read our follow-up interview with Dr. Banerjee on her research progress and how the grants she’s received have impacted her and the work she is doing.
What is the project you have been working on?
I have been researching the role of the specific sodium channel in the heart, how it affects the conductance in patients with pulmonary arterial hypertension, and how it might affect RV function. We know in some sources that about 25% of patients with PAH can die of sudden cardiac death, and sudden cardiac death is more common in patients with left-sided heart disease.
Instead of dying of sudden death or end stage heart failure, we wanted a way to see, just based on a physical exam, if there’s evidence of heart pump function not working well. With the funding, I’ve been able to more than double the sample size of the original pilot data and add in two more large objectives to complement my original aim.
What has receiving the grant meant to you?
One of the reasons I was able to stay at Brown was because of winning this grant from the CHEST Foundation. It was able to cement my interest in fully pursuing a physician scientist career, which is huge, because it is not what I had planned on doing. Because of this grant, I had an 80% protected research position in my first year. Winning the grant gave me a feeling of affirmation and validation, and that certainly motivates me to continue on this path.
Going into fellowship, if you had asked me what I had envisioned myself doing, I would have said I’d be a medical educator. I think I was surprised by my research year in fellowship when I was working on this project, because the grant created so much excitement. I felt like I could actually do this, and obtaining the grant uped the ante of investment and kept me excited. Plus, the grant allowed me to do everything, see the whole process, the full arc, and I’m not even done.
What barriers have you encountered with your research?
Dr. Debasree Banerjee
Not having all the control, like unplanned hospitalizations or advanced sickness in the patients. There are also things cost-wise that are needed for the research that I wouldn’t have had access to without the grant. I didn’t do much research in medical school and residency, since I was more focused on teaching, so I hadn’t been prepared for the administrative legwork. But, it’s something I’m learning.
Being able to follow up with the CHEST Foundation and attend the CHEST annual meeting are exciting ways to overcome any slumps or doubts, because you see the interest and encouragement for the work you’re doing. Receiving the travel grant and coming to the annual meeting as a new faculty member, it was the most high-yield conference I’ve ever attended. Every day, there is something new and interactive for development.
What advice would you give to someone who hasn’t received a grant before but is considering applying?
If they can get a good mentor, that’s invaluable. It takes perseverance, persistence, and passion, and if you believe your work is having an impact, it’s absolutely worth doing. Even if you apply and don’t get it the first time, try, try again. I have so much more faith in CHEST because of the positivity I see from the investment in my own mentor, who was a past foundation grant recipient and encouraged me to apply. CHEST gives ample opportunity to network and help to be steered in the right way. As a grant recipient and being folded into the CHEST community, you start to think, “I want this feeling again. Someone thinks this is important work.”
In 2015, Debasree Banerjee, MD, MS, received the CHEST Foundation Research Grant in Pulmonary Arterial Hypertension. She was also a 2016 NetWorks Challenge Travel Grantee as a member of the Women’s Health NetWork, allowing her to attend the 2016 CHEST Annual Meeting and network with peers and leaders in chest medicine. Read our follow-up interview with Dr. Banerjee on her research progress and how the grants she’s received have impacted her and the work she is doing.
What is the project you have been working on?
I have been researching the role of the specific sodium channel in the heart, how it affects the conductance in patients with pulmonary arterial hypertension, and how it might affect RV function. We know in some sources that about 25% of patients with PAH can die of sudden cardiac death, and sudden cardiac death is more common in patients with left-sided heart disease.
Instead of dying of sudden death or end stage heart failure, we wanted a way to see, just based on a physical exam, if there’s evidence of heart pump function not working well. With the funding, I’ve been able to more than double the sample size of the original pilot data and add in two more large objectives to complement my original aim.
What has receiving the grant meant to you?
One of the reasons I was able to stay at Brown was because of winning this grant from the CHEST Foundation. It was able to cement my interest in fully pursuing a physician scientist career, which is huge, because it is not what I had planned on doing. Because of this grant, I had an 80% protected research position in my first year. Winning the grant gave me a feeling of affirmation and validation, and that certainly motivates me to continue on this path.
Going into fellowship, if you had asked me what I had envisioned myself doing, I would have said I’d be a medical educator. I think I was surprised by my research year in fellowship when I was working on this project, because the grant created so much excitement. I felt like I could actually do this, and obtaining the grant uped the ante of investment and kept me excited. Plus, the grant allowed me to do everything, see the whole process, the full arc, and I’m not even done.
What barriers have you encountered with your research?
Dr. Debasree Banerjee
Not having all the control, like unplanned hospitalizations or advanced sickness in the patients. There are also things cost-wise that are needed for the research that I wouldn’t have had access to without the grant. I didn’t do much research in medical school and residency, since I was more focused on teaching, so I hadn’t been prepared for the administrative legwork. But, it’s something I’m learning.
Being able to follow up with the CHEST Foundation and attend the CHEST annual meeting are exciting ways to overcome any slumps or doubts, because you see the interest and encouragement for the work you’re doing. Receiving the travel grant and coming to the annual meeting as a new faculty member, it was the most high-yield conference I’ve ever attended. Every day, there is something new and interactive for development.
What advice would you give to someone who hasn’t received a grant before but is considering applying?
If they can get a good mentor, that’s invaluable. It takes perseverance, persistence, and passion, and if you believe your work is having an impact, it’s absolutely worth doing. Even if you apply and don’t get it the first time, try, try again. I have so much more faith in CHEST because of the positivity I see from the investment in my own mentor, who was a past foundation grant recipient and encouraged me to apply. CHEST gives ample opportunity to network and help to be steered in the right way. As a grant recipient and being folded into the CHEST community, you start to think, “I want this feeling again. Someone thinks this is important work.”
In 2015, Debasree Banerjee, MD, MS, received the CHEST Foundation Research Grant in Pulmonary Arterial Hypertension. She was also a 2016 NetWorks Challenge Travel Grantee as a member of the Women’s Health NetWork, allowing her to attend the 2016 CHEST Annual Meeting and network with peers and leaders in chest medicine. Read our follow-up interview with Dr. Banerjee on her research progress and how the grants she’s received have impacted her and the work she is doing.
What is the project you have been working on?
I have been researching the role of the specific sodium channel in the heart, how it affects the conductance in patients with pulmonary arterial hypertension, and how it might affect RV function. We know in some sources that about 25% of patients with PAH can die of sudden cardiac death, and sudden cardiac death is more common in patients with left-sided heart disease.
Instead of dying of sudden death or end stage heart failure, we wanted a way to see, just based on a physical exam, if there’s evidence of heart pump function not working well. With the funding, I’ve been able to more than double the sample size of the original pilot data and add in two more large objectives to complement my original aim.
What has receiving the grant meant to you?
One of the reasons I was able to stay at Brown was because of winning this grant from the CHEST Foundation. It was able to cement my interest in fully pursuing a physician scientist career, which is huge, because it is not what I had planned on doing. Because of this grant, I had an 80% protected research position in my first year. Winning the grant gave me a feeling of affirmation and validation, and that certainly motivates me to continue on this path.
Going into fellowship, if you had asked me what I had envisioned myself doing, I would have said I’d be a medical educator. I think I was surprised by my research year in fellowship when I was working on this project, because the grant created so much excitement. I felt like I could actually do this, and obtaining the grant uped the ante of investment and kept me excited. Plus, the grant allowed me to do everything, see the whole process, the full arc, and I’m not even done.
What barriers have you encountered with your research?
Dr. Debasree Banerjee
Not having all the control, like unplanned hospitalizations or advanced sickness in the patients. There are also things cost-wise that are needed for the research that I wouldn’t have had access to without the grant. I didn’t do much research in medical school and residency, since I was more focused on teaching, so I hadn’t been prepared for the administrative legwork. But, it’s something I’m learning.
Being able to follow up with the CHEST Foundation and attend the CHEST annual meeting are exciting ways to overcome any slumps or doubts, because you see the interest and encouragement for the work you’re doing. Receiving the travel grant and coming to the annual meeting as a new faculty member, it was the most high-yield conference I’ve ever attended. Every day, there is something new and interactive for development.
What advice would you give to someone who hasn’t received a grant before but is considering applying?
If they can get a good mentor, that’s invaluable. It takes perseverance, persistence, and passion, and if you believe your work is having an impact, it’s absolutely worth doing. Even if you apply and don’t get it the first time, try, try again. I have so much more faith in CHEST because of the positivity I see from the investment in my own mentor, who was a past foundation grant recipient and encouraged me to apply. CHEST gives ample opportunity to network and help to be steered in the right way. As a grant recipient and being folded into the CHEST community, you start to think, “I want this feeling again. Someone thinks this is important work.”
In keeping with the commitment of the American College of Chest Physicians (CHEST) to be the home of the clinician educator, and supporting CHEST’s strategic vision of advancing best patient outcomes through innovative chest medicine education, a new designation intended to provide national-level recognition of excellence in continuing medical education has been established—the innovation award-winning Distinguished CHEST Educator.
Distinguished CHEST Educators are within the top 5% of CHEST’s faculty and are recognized for their achievements in making significant and long-term contributions to the design and delivery of CHEST education. With more than 108 ways to educate, these faculty members have exceeded expectations by serving as CHEST committee chairs, vice-chairs, faculty, and peer reviewers for programs such as the CHEST Annual Meeting.
“The greatest achievement I can imagine is seen in the people we train—as that lives on. Real values in medicine live only by being handed down to others. Over the past decade, CHEST has afforded me the privilege to represent the organization on a national platform, and, in doing so, I have been able to refine my own skills and those of my peers, as well as adding both quality and detail to my understanding of how young physicians learn,” says Nader Kamangar, MD, FCCP, of UCLA, CHEST member since 2000, and Distinguished CHEST Educator.
This designation will be granted to select clinical educators each year. The inaugural class of Distinguished CHEST Educators was honored at the end of October at CHEST 2017 in Toronto, as will be the tradition for the classes that follow.
Distinguished CHEST Educator
Congratulations to the inaugural class of Distinguished CHEST Educators.
In keeping with the commitment of the American College of Chest Physicians (CHEST) to be the home of the clinician educator, and supporting CHEST’s strategic vision of advancing best patient outcomes through innovative chest medicine education, a new designation intended to provide national-level recognition of excellence in continuing medical education has been established—the innovation award-winning Distinguished CHEST Educator.
Distinguished CHEST Educators are within the top 5% of CHEST’s faculty and are recognized for their achievements in making significant and long-term contributions to the design and delivery of CHEST education. With more than 108 ways to educate, these faculty members have exceeded expectations by serving as CHEST committee chairs, vice-chairs, faculty, and peer reviewers for programs such as the CHEST Annual Meeting.
“The greatest achievement I can imagine is seen in the people we train—as that lives on. Real values in medicine live only by being handed down to others. Over the past decade, CHEST has afforded me the privilege to represent the organization on a national platform, and, in doing so, I have been able to refine my own skills and those of my peers, as well as adding both quality and detail to my understanding of how young physicians learn,” says Nader Kamangar, MD, FCCP, of UCLA, CHEST member since 2000, and Distinguished CHEST Educator.
This designation will be granted to select clinical educators each year. The inaugural class of Distinguished CHEST Educators was honored at the end of October at CHEST 2017 in Toronto, as will be the tradition for the classes that follow.
Distinguished CHEST Educator
Congratulations to the inaugural class of Distinguished CHEST Educators.
Sandra Adams, MD, MS, FCCP
Doreen Addrizzo-Harris, MD, FCCP
A. Christine Argento, MD, FCCP
Robert Arntfield, MD, FCCP
Anthony Asciutto, RRT
Olivier Axler, MD, PhD, FCCP
Meyer Balter, MD, FCCP
Gisela Banauch, MD, MS, FCCP
Robert Baughman, MD, FCCP
David Bell, MD, FCCP
Michel Boivin, MD, FCCP
Gabriel Bosslet, MD, FCCP
Jean Bourbeau, MD, MS, FCCP
David Bowton, MD, FCCP
Kevin Brown, MD, FCCP
Jack Buckley, MD, MPH, FCCP
Kristin Burkart, MD, MS, FCCP
Brian Carlin, MD, FCCP
Christopher Carroll, MD, FCCP
Roberto Casal, MD
Richard Castriotta, MD, FCCP
Kevin Chan, MD, FCCP
Alexander Chen, MD
Michael Christian, MD, FCCP
Nancy Collop, MD, FCCP
Clayton Cowl, MD, MS, FCCP
Angel Coz Yataco, MD, FCCP
Gerard Criner, MD, FCCP
Carolyn D’Ambrosio, MD, FCCP
Mauricio Danckers, MD, FCCP
Aneesa Das, MD, FCCP
John Davies, RRT, MA, FCCP
Frank Detterbeck, MD, FCCP
Emily Diederich, MD, FCCP
Kevin Doerschug, MD, MS, FCCP
Meagan Dubosky, RRT-ACCS
Kevin Dushay, MD, FCCP
Eric Edell, MD, FCCP
William Enfinger
Michael Ezzie, MD, FCCP
David Feller-Kopman, MD, FCCP
Kevin Felner, MD, FCCP
Neil Freedman, MD, FCCP
Thomas Fuhrman, MD, MS, FCCP
John Gaillard, MD, FCCP
Colin Gillespie, MD
Maritza Groth, MD, FCCP
Mark Hall, MD
Jesse Hall, MD, FCCP
Nicola Hanania, MD, MBBS, FCCP
D. Kyle Hogarth, MD, FCCP
Steven Hollenberg, MD, FCCP
Robert Hyzy, MD, FCCP
Richard Irwin, MD, Master FCCP
Nader Kamangar, MD, MS, FCCP
Carl Kaplan, MD, FCCP
Brian Kaufman, MD, FCCP
William Kelly, MD, FCCP
Seth Koenig, MD, FCCP
Anastassios Koumbourlis, MD, MPH, FCCP
Lindsey Kreisher, RRT
Karol Kremens, MD, FCCP
Sunita Kumar, MD, MBBS, FCCP
Viera Lakticova, MD
Carla Lamb, MD, FCCP
Hans Lee, MD, FCCP
Peter Lenz, MD, MEd, FCCP
Stephanie Levine, MD, FCCP
Deborah Levine, MD, MS, FCCP
Kenneth Lyn-Kew, MD
Joao Alberto de Andrade, MD, FCCP
Neil MacIntyre, MD, FCCP
Donald Mahler, MD, FCCP
Fabien Maldonado, MD, FCCP
Atul Malhotra, MD, FCCP
Haney Mallemat, MD
Darcy Marciniuk, MD, FCCP
Diego Maselli Caceres, MD, FCCP
Paul Mayo, MD, FCCP
Peter Mazzone, MD, MPH, FCCP
John McIlwaine, DO, MBA, FCCP
Mark Metersky, MD, FCCP
Scott Millington, MD
Taro Minami, MD, FCCP
Lisa Moores, MD, FCCP
Amy Morris, MD
John Mullon, MD, FCCP
Septimiu Murgu, MD, FCCP
Mangala Narasimhan, DO, FCCP
Michael Niederman, MD, FCCP
Alexander Niven, MD, FCCP
Anne O’Donnell, MD, FCCP
Erik Osborn, MD
David Ost, MD, MPH, FCCP
Ronald Oudiz, MD, FCCP
Daniel Ouellette, MD, MS, FCCP
Nicholas Pastis, MD, FCCP
Paru Patrawalla, MD, FCCP
Jay Peters, MD, FCCP
Barbara Phillips, MD, MSPH, FCCP
Margaret Pisani, MD, MS, FCCP
Janos Porszasz, MD, PhD
Whitney Prince, MD, FCCP
Suhail Raoof, MBBS, FCCP
Marcos Restrepo, MD, MSc, FCCP
Otis Rickman, DO, FCCP
Roy Ridgeway
Mary Ried, RN, CCRN
Antoni Rosell, MD
Mark Rosen, MD, Master FCCP
Bernard Roth, MD, FCCP
Anthony Saleh, MD, FCCP
Juan Sanchez, MD, FCCP
Pralay Sarkar, MBBS, FCCP
Lewis Satterwhite, MD, FCCP
Paul Scanlon, MD, FCCP
Gregory Schmidt, MD, FCCP
David Schulman, MD, MPH, FCCP
Brady Scott, RRT, MS
Bernardo Selim, MD, FCCP
Curtis Sessler, MD, FCCP
Rakesh Shah, MD, FCCP
Ray Wes Shepherd, MD, FCCP
John Sherner, MD, FCCP
Ariel Shiloh, MD
Samira Shojaee, MD, FCCP
Gerard Silvestri, MD, MS, FCCP
Steven Simpson, MD, FCCP
James Stoller, MD, MS, FCCP
Mary Strek, MD, FCCP
William Stringer, MD, FCCP
Eleanor Summerhill, MD, FCCP
Lynn Tanoue, MD, FCCP
Victor Test, MD, FCCP
Arthur Tokarczyk, MD, FCCP
Anil Vachani, MD, FCCP
Momen Wahidi, MD, MBA, FCCP
Keith Wille, MD, FCCP
Lisa Wolfe, MD, FCCP
Richard Wunderink, MD, FCCP
Lonny Yarmus, DO, FCCP
Kazuhiro Yasufuku, MD, PhD, FCCP
Gulrukh Zaidi, MD
In keeping with the commitment of the American College of Chest Physicians (CHEST) to be the home of the clinician educator, and supporting CHEST’s strategic vision of advancing best patient outcomes through innovative chest medicine education, a new designation intended to provide national-level recognition of excellence in continuing medical education has been established—the innovation award-winning Distinguished CHEST Educator.
Distinguished CHEST Educators are within the top 5% of CHEST’s faculty and are recognized for their achievements in making significant and long-term contributions to the design and delivery of CHEST education. With more than 108 ways to educate, these faculty members have exceeded expectations by serving as CHEST committee chairs, vice-chairs, faculty, and peer reviewers for programs such as the CHEST Annual Meeting.
“The greatest achievement I can imagine is seen in the people we train—as that lives on. Real values in medicine live only by being handed down to others. Over the past decade, CHEST has afforded me the privilege to represent the organization on a national platform, and, in doing so, I have been able to refine my own skills and those of my peers, as well as adding both quality and detail to my understanding of how young physicians learn,” says Nader Kamangar, MD, FCCP, of UCLA, CHEST member since 2000, and Distinguished CHEST Educator.
This designation will be granted to select clinical educators each year. The inaugural class of Distinguished CHEST Educators was honored at the end of October at CHEST 2017 in Toronto, as will be the tradition for the classes that follow.
Distinguished CHEST Educator
Congratulations to the inaugural class of Distinguished CHEST Educators.
Stephen J. Welch was officially appointed Executive Vice President and CEO in April after serving as the interim for both positions since May 2016. Here’s a little “inside look” at what Steve is all about.
What is one major accomplishment you hope to achieve as Executive Vice President & Chief Executive Officer?
My goal as EVP/CEO is fairly simple and straightforward: to ensure the organization remains relevant and viable as a leader in providing clinically focused, innovative educational programs and content. I don’t really have one accomplishment that I’m focused on, but I do want to ensure that we achieve our annual organizational goals that support CHEST’s strategic plan. That may sound a little vague, but it’s true. We have so many outstanding programs and initiatives that I’d be doing a disservice to identify a single goal.
How does your previous experience with CHEST help you successfully lead the organization?
With CHEST being a not-for-profit organization, which relies on volunteer leadership and faculty, I think the relationships I’ve built over the past 23 years within the organization and the chest medicine community are invaluable. I personally know so many of our leadership because I’ve been part of the organization at the executive level working with them for those 23 years. They know me and how I approach opportunities, address issues, and handle challenges, which has helped build an immediate level of mutual respect, trust, and confidence between the staff and leadership. In addition, there was no disruption from having someone come in from the outside and have to get up to speed. It made the transition pretty seamless for the staff, as well.
During my time at CHEST, I’ve seen how the organization operates, from the journal, to the annual meeting and board reviews, to the simulation and hands-on skills training, to operational activities like the management of our finances and new global headquarters and training center. I’ve also had the opportunity to meet with many of our international members and sister societies. Those experiences have allowed me to work closely with many of our faculty, authors, and educators to understand their educational and professional needs, so we can ensure that we meet them.
CHEST is only as good as the education we provide, and it’s our subject matter experts who drive that content engine. In my previous role leading the Publishing Division and working on our journal CHEST® and programs like SEEK, I’ve had the honor and pleasure of working with some of the greatest minds in pulmonary, critical care, and sleep medicine. It’s humbling.
What will be some of the underlying themes as you work to outline the strategic plan for the next 5 years?
We are in the final stages of planning for 2018 and beyond, and although our proposed roadmap isn’t significantly different than what we have been doing, there’s some greater emphasis on a few key areas. For example, we’re looking at innovations in educational delivery. We’ve got some very forward thinking faculty educators and staff who are collaborating to develop innovations like gamification of educational and simulation programs, and augmented reality. Globalization and growth are also a key part of our strategic plan, and we are committed to the broad delivery of our educational programs and content both here and around the world. Finally, we have invested in a data analytics project that is maturing, and we’ll be leveraging that information to provide more personalized education plans – not just for the physician but for the entire health-care team. It’s important for us to stay relevant and viable.
Stephen J. Welch
Why has CHEST shifted to an interdisciplinary, team-focused approach?
I look at it as simply an evolution that reflects how health care is changing. It’s a team sport now, and our advanced practice providers (APPs) play a huge role in patient management and care. To be as effective and efficient as possible, and ensure the best patient outcomes, the whole team needs to be on the same page, and we believe that providing education for the interdisciplinary care team will help ensure that the best patient care is delivered.
There’s also a need for this education, and we want to fill it. Our APPs tell us that there is no formal pulmonary training or post-masters fellowship in pulmonary medicine for them. They are often left on their own to fill any gaps in knowledge and skills. That’s where our CHEST programs, such as our CHEST Annual Meeting, come in. We have an Interprofessional NetWork made up of APPs and physicians, and they were integral in working with the CHEST 2017 Program Committee to ensure plenty of relevant content was offered. Moving forward, we will continue to offer and build interdisciplinary programs designed for the entire team, as well as programs that address clinical issues across disciplines.
What are some of the critical skills CHEST physicians need to keep the population healthy during the ever-evolving field?
Educationally, we recognize that conferences like the annual CHEST meeting must provide more than just talking heads. We’ve invested heavily in high-fidelity medical simulation through small group, hands-on skill training in critical care techniques, airway management, EBUS, critical care ultrasound, bronchoscopy, and other chest medicine content. It’s like the old adage about fishing: instead of telling people how to fish, we teach them to fish.
Any final thoughts?
I always encourage our members to get involved with CHEST and experience the camaraderie and connectivity of the CHEST family. Ask any of our leadership, and you will surely hear their story of that special person who first introduced them to the College. Reach out and tell a colleague about CHEST. We are focused on clinically relevant education that our members can take back and put into action immediately. At the end of the day, it’s about providing state-of-the-art education via high fidelity medical simulation, hands-on skills training, clinically focused courses, case-based programming, and more—all intended to be immediately implemented to improve patient care and patient outcomes. That’s what the CHEST organization is all about.
Stephen J. Welch was officially appointed Executive Vice President and CEO in April after serving as the interim for both positions since May 2016. Here’s a little “inside look” at what Steve is all about.
What is one major accomplishment you hope to achieve as Executive Vice President & Chief Executive Officer?
My goal as EVP/CEO is fairly simple and straightforward: to ensure the organization remains relevant and viable as a leader in providing clinically focused, innovative educational programs and content. I don’t really have one accomplishment that I’m focused on, but I do want to ensure that we achieve our annual organizational goals that support CHEST’s strategic plan. That may sound a little vague, but it’s true. We have so many outstanding programs and initiatives that I’d be doing a disservice to identify a single goal.
How does your previous experience with CHEST help you successfully lead the organization?
With CHEST being a not-for-profit organization, which relies on volunteer leadership and faculty, I think the relationships I’ve built over the past 23 years within the organization and the chest medicine community are invaluable. I personally know so many of our leadership because I’ve been part of the organization at the executive level working with them for those 23 years. They know me and how I approach opportunities, address issues, and handle challenges, which has helped build an immediate level of mutual respect, trust, and confidence between the staff and leadership. In addition, there was no disruption from having someone come in from the outside and have to get up to speed. It made the transition pretty seamless for the staff, as well.
During my time at CHEST, I’ve seen how the organization operates, from the journal, to the annual meeting and board reviews, to the simulation and hands-on skills training, to operational activities like the management of our finances and new global headquarters and training center. I’ve also had the opportunity to meet with many of our international members and sister societies. Those experiences have allowed me to work closely with many of our faculty, authors, and educators to understand their educational and professional needs, so we can ensure that we meet them.
CHEST is only as good as the education we provide, and it’s our subject matter experts who drive that content engine. In my previous role leading the Publishing Division and working on our journal CHEST® and programs like SEEK, I’ve had the honor and pleasure of working with some of the greatest minds in pulmonary, critical care, and sleep medicine. It’s humbling.
What will be some of the underlying themes as you work to outline the strategic plan for the next 5 years?
We are in the final stages of planning for 2018 and beyond, and although our proposed roadmap isn’t significantly different than what we have been doing, there’s some greater emphasis on a few key areas. For example, we’re looking at innovations in educational delivery. We’ve got some very forward thinking faculty educators and staff who are collaborating to develop innovations like gamification of educational and simulation programs, and augmented reality. Globalization and growth are also a key part of our strategic plan, and we are committed to the broad delivery of our educational programs and content both here and around the world. Finally, we have invested in a data analytics project that is maturing, and we’ll be leveraging that information to provide more personalized education plans – not just for the physician but for the entire health-care team. It’s important for us to stay relevant and viable.
Stephen J. Welch
Why has CHEST shifted to an interdisciplinary, team-focused approach?
I look at it as simply an evolution that reflects how health care is changing. It’s a team sport now, and our advanced practice providers (APPs) play a huge role in patient management and care. To be as effective and efficient as possible, and ensure the best patient outcomes, the whole team needs to be on the same page, and we believe that providing education for the interdisciplinary care team will help ensure that the best patient care is delivered.
There’s also a need for this education, and we want to fill it. Our APPs tell us that there is no formal pulmonary training or post-masters fellowship in pulmonary medicine for them. They are often left on their own to fill any gaps in knowledge and skills. That’s where our CHEST programs, such as our CHEST Annual Meeting, come in. We have an Interprofessional NetWork made up of APPs and physicians, and they were integral in working with the CHEST 2017 Program Committee to ensure plenty of relevant content was offered. Moving forward, we will continue to offer and build interdisciplinary programs designed for the entire team, as well as programs that address clinical issues across disciplines.
What are some of the critical skills CHEST physicians need to keep the population healthy during the ever-evolving field?
Educationally, we recognize that conferences like the annual CHEST meeting must provide more than just talking heads. We’ve invested heavily in high-fidelity medical simulation through small group, hands-on skill training in critical care techniques, airway management, EBUS, critical care ultrasound, bronchoscopy, and other chest medicine content. It’s like the old adage about fishing: instead of telling people how to fish, we teach them to fish.
Any final thoughts?
I always encourage our members to get involved with CHEST and experience the camaraderie and connectivity of the CHEST family. Ask any of our leadership, and you will surely hear their story of that special person who first introduced them to the College. Reach out and tell a colleague about CHEST. We are focused on clinically relevant education that our members can take back and put into action immediately. At the end of the day, it’s about providing state-of-the-art education via high fidelity medical simulation, hands-on skills training, clinically focused courses, case-based programming, and more—all intended to be immediately implemented to improve patient care and patient outcomes. That’s what the CHEST organization is all about.
Stephen J. Welch was officially appointed Executive Vice President and CEO in April after serving as the interim for both positions since May 2016. Here’s a little “inside look” at what Steve is all about.
What is one major accomplishment you hope to achieve as Executive Vice President & Chief Executive Officer?
My goal as EVP/CEO is fairly simple and straightforward: to ensure the organization remains relevant and viable as a leader in providing clinically focused, innovative educational programs and content. I don’t really have one accomplishment that I’m focused on, but I do want to ensure that we achieve our annual organizational goals that support CHEST’s strategic plan. That may sound a little vague, but it’s true. We have so many outstanding programs and initiatives that I’d be doing a disservice to identify a single goal.
How does your previous experience with CHEST help you successfully lead the organization?
With CHEST being a not-for-profit organization, which relies on volunteer leadership and faculty, I think the relationships I’ve built over the past 23 years within the organization and the chest medicine community are invaluable. I personally know so many of our leadership because I’ve been part of the organization at the executive level working with them for those 23 years. They know me and how I approach opportunities, address issues, and handle challenges, which has helped build an immediate level of mutual respect, trust, and confidence between the staff and leadership. In addition, there was no disruption from having someone come in from the outside and have to get up to speed. It made the transition pretty seamless for the staff, as well.
During my time at CHEST, I’ve seen how the organization operates, from the journal, to the annual meeting and board reviews, to the simulation and hands-on skills training, to operational activities like the management of our finances and new global headquarters and training center. I’ve also had the opportunity to meet with many of our international members and sister societies. Those experiences have allowed me to work closely with many of our faculty, authors, and educators to understand their educational and professional needs, so we can ensure that we meet them.
CHEST is only as good as the education we provide, and it’s our subject matter experts who drive that content engine. In my previous role leading the Publishing Division and working on our journal CHEST® and programs like SEEK, I’ve had the honor and pleasure of working with some of the greatest minds in pulmonary, critical care, and sleep medicine. It’s humbling.
What will be some of the underlying themes as you work to outline the strategic plan for the next 5 years?
We are in the final stages of planning for 2018 and beyond, and although our proposed roadmap isn’t significantly different than what we have been doing, there’s some greater emphasis on a few key areas. For example, we’re looking at innovations in educational delivery. We’ve got some very forward thinking faculty educators and staff who are collaborating to develop innovations like gamification of educational and simulation programs, and augmented reality. Globalization and growth are also a key part of our strategic plan, and we are committed to the broad delivery of our educational programs and content both here and around the world. Finally, we have invested in a data analytics project that is maturing, and we’ll be leveraging that information to provide more personalized education plans – not just for the physician but for the entire health-care team. It’s important for us to stay relevant and viable.
Stephen J. Welch
Why has CHEST shifted to an interdisciplinary, team-focused approach?
I look at it as simply an evolution that reflects how health care is changing. It’s a team sport now, and our advanced practice providers (APPs) play a huge role in patient management and care. To be as effective and efficient as possible, and ensure the best patient outcomes, the whole team needs to be on the same page, and we believe that providing education for the interdisciplinary care team will help ensure that the best patient care is delivered.
There’s also a need for this education, and we want to fill it. Our APPs tell us that there is no formal pulmonary training or post-masters fellowship in pulmonary medicine for them. They are often left on their own to fill any gaps in knowledge and skills. That’s where our CHEST programs, such as our CHEST Annual Meeting, come in. We have an Interprofessional NetWork made up of APPs and physicians, and they were integral in working with the CHEST 2017 Program Committee to ensure plenty of relevant content was offered. Moving forward, we will continue to offer and build interdisciplinary programs designed for the entire team, as well as programs that address clinical issues across disciplines.
What are some of the critical skills CHEST physicians need to keep the population healthy during the ever-evolving field?
Educationally, we recognize that conferences like the annual CHEST meeting must provide more than just talking heads. We’ve invested heavily in high-fidelity medical simulation through small group, hands-on skill training in critical care techniques, airway management, EBUS, critical care ultrasound, bronchoscopy, and other chest medicine content. It’s like the old adage about fishing: instead of telling people how to fish, we teach them to fish.
Any final thoughts?
I always encourage our members to get involved with CHEST and experience the camaraderie and connectivity of the CHEST family. Ask any of our leadership, and you will surely hear their story of that special person who first introduced them to the College. Reach out and tell a colleague about CHEST. We are focused on clinically relevant education that our members can take back and put into action immediately. At the end of the day, it’s about providing state-of-the-art education via high fidelity medical simulation, hands-on skills training, clinically focused courses, case-based programming, and more—all intended to be immediately implemented to improve patient care and patient outcomes. That’s what the CHEST organization is all about.
